IP Library Assignment 029277/0713
Patent Assignment
Reel/Frame 029277/0713

Assignment of Assignor's Interest

Recorded: 2012-11-12 Pages: 6
Assignor
BAYER PHARMA AKTIENGESELLSCHAFT
Executed: 2012-08-01
Assignee
BAYER INTELLECTUAL PROPERTY GMBH
ALFRED-NOBEL-STRASSE 10, MONHEIM AM RHEIN, 40789, GERMANY
Covered Properties (19)
Substituted Oxazolidinones and Their Use in the Field of Blood Coagulation
Patent: 7,157,456 →
Application: 10/181,051 →
Publication: US 2003/0153610
Substituted Oxazolidinones for Combinational Therapy
Patent: 7,767,702 →
Application: 10/481,297 →
Publication: US 2004/0242660
Process for the Preparation of a Solid, Orally Administrable Pharmaceutical Composition
Application: 10/580,711 →
Publication: US 2008/0026057
Preparation Process
Patent: 7,351,823 →
Application: 11/032,815 →
Publication: US 2005/0182055
Solid, modified-release pharmaceutical dosage forms which can be administered orally
Application: 11/317,720 →
Publication: US 2007/0026065
Substituted Oxazolidinones and Their Use in the Field of Blood Coagulation
Patent: 7,592,339 →
Application: 11/460,529 →
Publication: US 2006/0258724
Prevention and Treatment of Thromboembolic Disorders
Patent: 9,539,218 →
Application: 11/883,218 →
Publication: US 2009/0004265
Substituted Oxazolidinones and Their Use in the Field of Blood Coagulation
Patent: 7,576,111 →
Application: 11/932,082 →
Publication: US 2008/0090815
2-Aminoethoxyacetic Acid Derivatives and Their Use
Patent: 7,932,278 →
Application: 11/992,396 →
Publication: US 2009/0036504
Substituted Oxazolidinones and Their Use in the Field of Blood Coagulation
Patent: 7,585,860 →
Application: 12/027,553 →
Publication: US 2008/0200674
Novel Polymorphous Form of 5-Chloro-N-({(5S)-2-Oxo-3[4-(3-Oxo-4-Morpholinyl)-Phenyl]-1,3-Oxazolidine-5-Yl}-Methyl)-2-Thiophene Carboxamide
Patent: 8,188,270 →
Application: 12/089,095 →
Publication: US 2010/0152189
Solid Orally Administerable Pharmaceutical Dosage Forms with Rapid Active Principle Release
Patent: 8,586,082 →
Application: 12/089,148 →
Publication: US 2010/0151011
Substituted Oxazolidinones and Their Use in the Field of Blood Coagulation
Patent: 8,129,378 →
Application: 12/494,879 →
Publication: US 2010/0137274
Combination Therapy of Substituted Oxazolidinones
Application: 12/513,363 →
Publication: US 2010/0120718
Method for Producing 5-Chloro-N-({(5S)-2-Oxo-3-[4-(3-Oxo-4-Morpholinyl)Phenyl]-1,3-Oxazolidin-5-Yl}Methyl)-2-Thiophenecarboxamide
Patent: 8,106,192 →
Application: 12/556,158 →
Publication: US 2010/0081807
Oxazolidinones For the Treatment and/or Prophylaxis of Heart Failure
Application: 12/746,661 →
Publication: US 2011/0003804
Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones
Application: 12/766,365 →
Publication: US 2010/0267685
Co-Crystal Compound of Rivaroxaban and Malonic Acid
Patent: 8,466,280 →
Application: 12/997,474 →
Publication: US 2011/0152266
Substituted Oxazolidinones and Their Use in the Field of Blood Coagulation
Patent: 8,530,505 →
Application: 13/360,107 →
Publication: US 2013/0005701
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →
Assignment of Assignor's Interest Feb 24, 2011
From: GRUNENBERG, ALFONS; FAEHNRICH, KARSTEN; QUECKENBERG, OLAF; REUTE, CHRISTIANE
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 025879/0659 →
Change of Name Dec 6, 2012
From: BAYER SCHERING PHARMA AG
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029418/0001 →
Change of Name Dec 6, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029418/0318 →
Change of Address Jun 12, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 064021/0344 →